AIFF Company Profile and Key Details

Firefly Neuroscience, Inc. generated EPS of -$2.53 over the past year. Five-year average earnings growth is 3.61%.

Firefly Neuroscience, Inc. has 14.21 million shares outstanding. The public float is 11.84 million shares, elevated short interest at 3.28% of float. This equals 391.33 thousand shares. The short ratio is 5.53 days. Institutional investors hold 10.02% of the float. Insiders own 29.48%. Over the past six months, insider transactions show net selling. They sold 400.00 thousand shares across 10 transactions.

Short-term trend indicators are bullishly aligned (SMA20 -8.4%, SMA50 -28.01%, SMA200 -68.67%). The stock’s 14-day RSI is 33.68 (weak momentum), while the ATR of 0.06 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -88.57% below its high and over 11.98% above its low. Average 10-day trading volume of 17.79 million shares is significantly above the 3-month average of 2.25 million, indicating heightened recent market interest.

Firefly Neuroscience, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.17. This means the shares are trading above this model’s fair value.

Firefly Neuroscience, Inc. (NASDAQ:AIFF) closed at $2.75 USD, gaining $1.01 (58.05%) from the previous close of $1.74. The stock is currently mid-range between its 52-week high and low $0.62 and $6.00. With a market capitalization of about $39.09 million, Firefly Neuroscience, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.93). Key stats such as the average daily volume over the past year has been around 6.52 million shares, trading with heavier-than-usual volume. Headquartered in Kenmore, ON, Firefly Neuroscience, Inc. operates in the Technology sector and the Software - Application industry. Led by CEO Greg Lipschitz, the company employs approximately 13 people and listed since November 28, 2002. Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders.

Firefly Neuroscience, Inc. trades at a P/E ratio of -1.61, slightly below the S&P 500 average, with a price-to-sales ratio of 46.96 and a price-to-book ratio of 3.53 trading at moderately above to book value. The P/FCF stands at -4.72, also below market averages.

Firefly Neuroscience, Inc. (NASDAQ:AIFF) shares are up 13.29% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Firefly Neuroscience, Inc. trading at a premium to the broader market with a P/E of -1.61. Our AI forecast model points to short-term weakness (-35.27% over two weeks), a medium-term rise (180.0% over three months), and a longer-term loss (-79.64% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Firefly Neuroscience, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -35.27%, with price expected at $1.78 by March 26, 2026, within a range of $1.40 to $2.18 3-Month Outlook: Projected rise of 180.0%, reaching $7.70 by June 10, 2026, with a range of $5.38 to $8.59. 1-Year Outlook: Projected loss of -79.64%, with price at $0.56 by March 12, 2027, within a range of $0.00 to $0.86.